Notable Labs Income After Taxes 2013-2024 | NTBLQ
Notable Labs income after taxes from 2013 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Notable Labs Annual Income After Taxes
(Millions of US $) |
| 2023 |
$-11 |
| 2022 |
$-14 |
| 2021 |
$-30 |
| 2020 |
$-24 |
| 2019 |
$-19 |
| 2018 |
$-20 |
| 2017 |
$-10 |
| 2016 |
$-16 |
| 2015 |
$-15 |
| 2014 |
$-17 |
| 2013 |
$-17 |
| 2012 |
$-12 |
Notable Labs Quarterly Income After Taxes
(Millions of US $) |
| 2024-06-30 |
$-5 |
| 2024-03-31 |
$-4 |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$-1 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-6 |
| 2022-12-31 |
$15 |
| 2022-09-30 |
$-9 |
| 2022-06-30 |
$-9 |
| 2022-03-31 |
$-10 |
| 2021-12-31 |
$-9 |
| 2021-09-30 |
$-7 |
| 2021-06-30 |
$-8 |
| 2021-03-31 |
$-6 |
| 2020-12-31 |
$-7 |
| 2020-09-30 |
$-6 |
| 2020-06-30 |
$-6 |
| 2020-03-31 |
$-5 |
| 2019-12-31 |
$-6 |
| 2019-09-30 |
$-5 |
| 2019-06-30 |
$-5 |
| 2019-03-31 |
$-4 |
| 2018-12-31 |
$-4 |
| 2018-09-30 |
$-5 |
| 2018-06-30 |
$-4 |
| 2018-03-31 |
$-7 |
| 2017-12-31 |
$6 |
| 2017-09-30 |
$-7 |
| 2017-06-30 |
$-5 |
| 2017-03-31 |
$-5 |
| 2016-12-31 |
$-5 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-3 |
| 2016-03-31 |
$-5 |
| 2015-12-31 |
$-3 |
| 2015-09-30 |
$-6 |
| 2015-06-30 |
$-3 |
| 2015-03-31 |
$-3 |
| 2014-12-31 |
$-5 |
| 2014-09-30 |
$-4 |
| 2014-06-30 |
$-4 |
| 2014-03-31 |
$-5 |
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2012-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
